Korea Research Institute of Bioscience and Biotechnology (KRIBB)
The Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a premier government-funded research institute in South Korea, operating under the Ministry of Science and ICT. It is not a commercial, for-profit company, but a national entity dedicated to leading the nation's research and development in the life sciences and biotechnology. KRIBB's core mission is to act as a national hub for biotech innovation, contributing to public health, environmental sustainability, and the growth of the bio-economy.
Headquartered in Daejeon's Daedeok Innopolis, the heart of South Korea's R&D cluster, KRIBB's "business" is the creation of original scientific knowledge, the development of source technologies, and the management of critical national bio-infrastructure. The institute plays a pivotal role in the entire innovation ecosystem, conducting everything from fundamental research into the basic principles of life to applied research that can be transferred to the private sector for commercialization.
Continue…
Core Business: A National Hub for Biotechnology R&D
KRIBB's operations are built on three fundamental pillars that define its national role.
Pioneering Research: The primary function of KRIBB is to conduct cutting-edge research to solve major challenges in health, food, and the environment. This involves exploring new scientific frontiers, developing platform technologies, and securing intellectual property that forms the basis for future industries.
Management of National Bio-Infrastructure: KRIBB is entrusted with the establishment and operation of critical national infrastructure for biotechnology research. This includes managing vast biological resource banks (like gene banks and microbial collections), which are essential for researchers across the country.
Technology Transfer and Commercialization: A key part of its mandate is to ensure that the scientific discoveries made in its labs have a real-world impact. KRIBB actively works to transfer its technologies to pharmaceutical, chemical, and biotech companies, with a particular focus on supporting the growth of innovative small and medium-sized enterprises (SMEs).
"Products and Services" (Research and Infrastructure Offerings)
As a national institute, KRIBB's "products and services" are the tangible scientific outputs, technologies, and unique resources it provides to the government, industry, and the entire research community.
1. Research and Development
The primary "product" of KRIBB is the novel technology and intellectual property (patents) it generates.
- Key Research Areas:
- New Drug Discovery: A major focus is on discovering and developing novel therapeutic candidates. This includes research into anti-cancer drugs, treatments for rare and incurable diseases, and next-generation therapies like gene and cell therapy.
- Industrial Biotechnology: Developing eco-friendly bioprocesses to produce high-value chemicals, biofuels, and bioplastics from renewable resources. This involves metabolic engineering of microorganisms to create cellular "factories."
- Environmental and Agricultural Biotechnology: Researching solutions for environmental remediation (e.g., using microbes to clean up pollutants) and developing technologies to improve crop yields and resilience.
- Genomics and Synthetic Biology: Conducting large-scale genome sequencing and analysis, and designing and synthesizing artificial biological systems to create new functions. This is the foundation for much of their advanced research.
- Aging Science: A specialized area focusing on understanding the biological mechanisms of aging and developing interventions to promote healthy longevity.
2. National Bio-Infrastructure and Resource Services
This is a critical national "service" that KRIBB provides to the entire Korean research community.
Korea Bio-Resource Center (KBRC): KRIBB operates the KBRC, which serves as the national headquarters for biological resources. This includes:
- The National Gene Bank: A massive repository that preserves genetic resources from humans, animals, plants, and microorganisms.
- Microbial Culture Collections: Maintaining and distributing a vast and diverse collection of authenticated microbial strains for use in academic and industrial research.
- Distribution Service: Provides researchers across Korea with access to high-quality, authenticated biological materials for their experiments.
National Primate Research Center (NPRC): KRIBB operates the NPRC, a state-of-the-art facility for research using non-human primates. This is an essential infrastructure for preclinical testing of new drugs and therapies before they can move to human clinical trials.
3. Technology Transfer and Industry Support
KRIBB is committed to translating its research into economic value.
- Licensing of Technologies: The institute actively licenses its patents and know-how to private companies, enabling them to develop and commercialize new products.
- Joint R&D and Contract Research: KRIBB collaborates directly with companies on joint research projects. Businesses can also commission KRIBB to perform specific, confidential research on their behalf.
- Support for Bio-Venture Companies: The institute runs an incubation center and support programs to help researchers and entrepreneurs launch new biotech startups based on KRIBB's technologies.
4. Analytical and Testing Services
- The Service: KRIBB provides highly specialized, fee-based analytical services that are not readily available elsewhere. This includes access to its advanced equipment and expertise for things like:
- Large-scale DNA/RNA sequencing and analysis.
- Advanced bio-imaging using high-resolution microscopy.
- Protein structure analysis.
- Preclinical efficacy and safety testing.
